Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study
PHARMACOGENETICS AND GENOMICS
Authors: Patrignani, Paola; Di Febbo, Concetta; Tacconelli, Stefania; Douville, Karen; Guglielmi, Maria D.; Horvath, Ryan J.; Ding, Min; Sierra, Kent; Stitham, Jeremiah; Gleim, Scott; Baccante, Giovanna; Moretta, Valeria; Di Francesco, Luigia; Capone, Marta L.; Porreca, Ettore; Hwa, John
Abstract
Objective and methods The role of prostacyclin in the development of venous thrombosis and vascular dysfunction in humans is unclear. In patients with deep vein thrombosis (DVT, n=34) and controls (matched for age, sex, indexes of systemic inflammation and metabolic status, n=20), we studied (i) differences on systemic markers of vascular disease and platelet activation and 00 the influence of prostacyclin receptor gene (PTGIR) polymorphisms. Main results Enhanced levels of urinary 11-dehydrothromboxane (TX)B(2) and plasma [soluble(s)] P-selectin, mostly platelet derived, were detected in DVT patients, whereas plasma von Willebrand factor levels and intimamedia thickness of the common carotid arteries were not significantly different. In all patients' cohorts, we identified five PTGIR polymorphisms (three nonsynonymous: P226T, R212C, V196L; two synonymous: V53V, S328S). In the four individuals carriers of R212C polymorphism (three in DVT, one in controls), intima-media thickness values were significantly (P=0.0043) higher than those detected in individuals of all cohorts [1.68 +/- 0.38,1.55 (1.4-2.2) vs. 1.05 +/- 0.33, 1.08 (0.01-1.68) mm, respectively, mean SD, median (range)]. Moreover, enhanced sP-selectin and 11-dehydro-TXB(2), in DVT versus controls, were statistically significant only in carriers of both synonymous PTGIR polymorphisms V53V/S328S. Only the PTGIR mutant R212C was dysfunctional when examined in an in vitro overexpression system. Conclusion Our results suggest a propensity of enhanced platelet activation in DVT patients with PTGIR polymorphisms V53V/S328S. Moreover, we identified a dysfunctional PTGIR polymorphism (R212C) associated with intimal hyperplasia. Pharmacogenetics and Genomics 18:611-620 (c) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
Isolation of luteal endothelial cells and functional interactions with T lymphocytes
REPRODUCTION
Authors: Walusimbi, S. S.; Wetzel, L. M.; Townson, D. H.; Pate, J. L.
Abstract
The objectives of this study were to optimize the isolation of luteal endothelial cells (LEC) and examine their functional interactions with autologous T lymphocytes. Analysis by flow cytometry showed that the purity of LEC isolated by filtration was nearly 90% as indicated by Bandeiraea simplicifolia (BS)-1 lectin binding. LEC expressed mRNA for progesterone receptor (PGR), prostaglandin receptors (PTGFR, PTGER2 and 4, and PTGIR), tumor necrosis factor receptors (TNFRSF1A&B) and interleukin (IL) 1B receptors (IL1R1&2). LEC were pretreated with either vehicle, progesterone (P-4; 0-20 mu M), prostaglandin (PG) E-2 or PGF(2 alpha) (0-0.2 mu M), and further treated with or without TNF and IL1B (50 ng/mL each). LEC were then incubated with autologous T lymphocytes in an adhesion assay. Fewer lymphocytes adhered to LEC after exposure to high compared to low P-4 concentrations (cubic response; P < 0.05). In contrast, 0.2 mu M PGE(2) and PGF(2 alpha) each increased T lymphocyte adhesion in the absence of cytokines (P < 0.05). LEC induced IL2 receptor alpha (CD25) expression and proliferation of T lymphocytes. In conclusion, filtration is an effective way of isolating large numbers of viable LEC. It is proposed that PGs and P-4 modulate the ability of endothelial cells to bind T lymphocytes, potentially regulating extravasation, and that LEC activate T lymphocytes migrating into or resident in the CL.